Simulations Plus, Inc. (SLP)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Simulations Plus, Inc. chart...

About the Company

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

Exchange

Nasdaq

$64M

Total Revenue

108

Employees

$887M

Market Capitalization

77.27

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SLP News

Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript

14d ago, source: InvestingChannel on MSN

Q2 2024 Earnings Call April 3, 2024 Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.1983, expectations ...

Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session

on MSN ago, source:

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday. Shares of ...

Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year

12d ago, source: Yahoo Finance

Simulations Plus, Inc. (NASDAQ:SLP) investors will be delighted, with the company turning in some strong numbers with its ...

Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA

10d ago, source: Zacks.com on MSN

Simulations Plus SLP recently announced that the FDA (United States Food and Drug Administration) has renewed its DILIsym ...

Simulations Plus: Fiscal Q2 Earnings Snapshot

15d ago, source: The Washington Post

LANCASTER, Calif. — LANCASTER, Calif. — Simulations Plus Inc. (SLP) on Wednesday reported net income of $4 million in its fiscal second quarter. The Lancaster, California-based company said it had net ...

InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance

1d ago, source: TMCnet

InnoGI Technologies (formerly The TIM Company) is pleased to announce an exciting, market-driven collaboration with Simulations Plus to combine its TIM Technology, part of the InnoGI SurroGUT ™ ...

Military contractor Cole Engineering's U.K. expansion to bring more business here

10d ago, source:

Vice President Brian Serra of Cole Engineering, who oversees acquisition initiatives, told Orlando Business Journal, the ...

Simulations Plus Second Quarter 2024 Earnings: Beats Expectations

13d ago, source:

Revenue exceeded analyst estimates by 5.9%. Earnings per share (EPS) also surpassed analyst estimates by 5.3%. Looking ahead, ...

Why Reliance Global Group Shares Are Trading Lower By Around 11%; Here Are 20 Stocks Moving Premarket

13d ago, source:

Shares of Reliance Global Group, Inc. (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial results for the year ended Dec 31, 2023.

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

on MSN ago, source:

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3% ...

Weekly Bund Yield Forecast, April 5: Bund Forward Rates, Like Treasuries, Shift Up

9d ago, source:

The inverted Bund yields continued this week with the negative 2-year/10-year yield spread at negative 47.1 basis points ...

UWorld Roger vs. Becker CPA: Which Review Course is Better?

18h ago, source:

Compare course options, technology, support, and pricing to choose the best CPA exam prep for your learning style.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...